Catalyst Event
Biogen Inc (BIIB) · Other
From Akros U.S. Tech 100 Index (AUT100)
5/24/2026, 12:00:00 AM
U.S. FDA decision (PDUFA date) for LEQEMBI IQLIK (lecanemab) subcutaneous autoinjector for treatment initiation in Alzheimer's disease on 2026-05-24; high importance is estimated as FDA approval for a major drug formulation typically results in ≥10% price impact, scheduled.
Korean Translation
2026-05-24로 예정된 알츠하이머병 츘료제 레쯀비 아이클릭(레카네맙) 피하 자가주사제의 츘료 시작에 대한 미국 FDA 결정(PDUFA)이며, 주요 약물의 제형 승인은 통상 10% 이상의 주가 변동을 야기하므로 높은 중요도로 예정됨.
Related Recent Events
CrowdStrike Holdings Inc (CRWD) · Earnings Release
Next earnings release for Q1 2027 is scheduled for 2026-06-09, with analysts forecasting an EPS of $1.07 estimated.
6/9/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Q4 and Full-Year Fiscal Year 2026 financial results scheduled; expected to have a medium impact as annual results typically influence guidance and investor sentiment.
5/20/2026, 12:00:00 AM
Fair Isaac Corporation (FICO) · Other
FICO World 2026 is scheduled to take place from May 19-22, 2026.
5/19/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Other
Google I/O 2026 developer conference is scheduled for 2026-05-19. Developer conferences usually have a 1-5% price impact. Updates on AI, Gemini, and Android are expected.
5/19/2026, 12:00:00 AM
GE Aerospace (GE) · Other
The 2026 Annual Shareholders Meeting to be held online on May 5, 2026, scheduled. Routine meetings typically result in minimal price movement.
5/5/2026, 12:00:00 AM
Cloudflare Inc (NET) · Earnings Release
Cloudflare's Q1 2026 earnings release is scheduled. The company forecasts revenue between $620.0 million and $621.0 million and an EPS of $0.23. High importance is estimated due to the potential for significant price volatility following the announcement scheduled.
4/30/2026, 12:00:00 AM